Key result
Candidate gene variants showed no significant overall association with non-osteoporotic fracture risk in physically active participants across any comparison model.
Why the study?
Do specific candidate gene risk alleles increase the risk of non-osteoporotic fractures in physically active humans?
Meta-Analysis (n=4,462)
Do specific candidate gene risk alleles increase the risk of non-osteoporotic fractures in physically active humans?
Candidate gene variants do not appear to have a significant overall effect on non-osteoporotic fracture risk in physically active individuals.
Answers are grounded in this paper and cite their sources.
No candidate variants associate with fracture risk overall in active populations; leaves open potential COL1A1 protection in females pending higher-quality studies.
Background: Fractures are common in physically active populations and genetic differences may mediate injury risk. Objective: To meta-analyse the pooled results of candidate gene association studies with non-osteoporotic fracture risk in physically active humans. Methods: Systematic searching of databases returned 11 eligible studies published in English. Pooled odds ratios (ORs) with 95% confidence intervals (CI) were produced using allele contrast, recessive and homozygote contrast meta-analysis models to evaluate associations of risk alleles in the COL1A1 (rs1800012), COL2A1 (rs412777), CTR (rs1801197), ESR1 (rs2234693 & rs9340799) LRP5 (rs3736228), VDR (rs10735810, rs7975232, rs1544410 & rs731236) genes with fracture incidence. Results: Eligible study quality was generally low (7/11) and no significant overall effect was found for any genetic variant with any comparison model (p >0.05). A trivial reduction in fracture risk was found for female participants with the COL1A1 Sp1 (rs1800012) T allele (OR = 0.48, 95% CI = 0.25 – 0.91, p = 0.03, d = -0.18). Conclusions: No overall effect was found from the pooled results of included genetic variants on fracture risk in physically active participants. The COL1A1 Sp1 rs1800012 T allele may reduce fracture risk in physically active females but further high-quality research with sex-specific analysis is required. Trial Registration: (PROSPERO; CRD42018115008).
No takes yet. Share an insight, caveat, or question.
Ryan-Moore et al. (2020) conducted a meta-analysis in Non-osteoporotic fracture risk (n=4,462). Candidate gene variants (e.g., COL1A1, VDR, LRP5) vs. Non-risk alleles / non-fracture controls was evaluated on Fracture incidence (overall effect for COL1A1 Sp1 rs1800012 T allele contrast) (OR 0.95, 95% CI 0.76-1.19, p=0.66). Candidate gene variants showed no significant overall association with non-osteoporotic fracture risk in physically active participants across any comparison model.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: